Kendall Lubeck
Internal Medicine · Littleton, CONPI 1427041920
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 274 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,563 and has fallen 99.2% since, to $13 in 2023. Among internal medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 274 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$786
- Amgen$453
- Johnson & Johnson$407
- AstraZeneca$303
- Pfizer$233
- Novo Nordisk$214
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,054100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $786 |
| Amgen(2 entities) | 27 | $453 |
| Johnson & Johnson(2 entities) | 25 | $407 |
| AstraZeneca | 16 | $303 |
| Pfizer | 27 | $233 |
| Novo Nordisk | 14 | $214 |
| Lilly USA, LLC | 14 | $182 |
| Novartis | 9 | $167 |
| Merck | 10 | $156 |
| GSK | 10 | $154 |
| Eisai Inc. | 8 | $111 |
| Boehringer Ingelheim | 5 | $69 |
| Amarin Pharma, Inc. | 4 | $62 |
| Biohaven Pharmaceuticals, Inc. | 3 | $56 |
| Ironwood Pharmaceuticals, Inc | 3 | $54 |
| E.r. Squibb & Sons, L.L.C. | 4 | $54 |
| Astellas Pharma US Inc | 3 | $53 |
| Kowa Pharmaceuticals America, Inc. | 4 | $53 |
| Sunovion Pharmaceuticals Inc. | 4 | $52 |
| Alfasigma USA, Inc. | 3 | $48 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| Gilead | 2 | $39 |
| IBSA Pharma Inc. | 2 | $32 |
| Bausch Health US, LLC | 1 | $25 |
| Neuronetics, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 2 | $23 |
| Bayer | 1 | $22 |
| GE HealthCare | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| Medtronic | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Promius Pharma LLC | 1 | $16 |
| Clarus Therapeutics Inc. | 2 | $15 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Optos, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$4,068 in reported general payments places this provider in the 90th percentile of 1,430 internal medicine providers in Colorado.
Other internal medicine in Littleton
- Sophia AmbrusoLittleton$62K
- Celinde StrohlLittleton$14K
- David ConwayLittleton$12K
- Pierre MalekLittleton$9K
- George FrankLittleton$9K
- Roger BowlesLittleton$6K
- Gilad GordonBoulder$476K
- Kathryn PolovitzParker$403K
- Monica GrafalsAvon$401K
- Luke WebbColorado Springs$287K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.